Project Grant HT9425261E340
Award Date 8/1/26
Completion Date 7/31/28
Dollars Obligated $560K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90033, USA
Similar Awards
- Federal Grant Award Summary The University of Southern California received a $871,500 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025 through August 31, 2028. The project, titled "YAP Inhibition for Treatment of Vestibular Schwannoma," supports investigator-initiated biomedical research addressing Service Member health priorities. This award aligns with the DHA's...
- Federal Grant Award Summary The University of Southern California received an $840,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to validate CCDC146 suppression as a therapeutic strategy for diverse forms of amyotrophic lateral sclerosis (ALS). The award, effective August 1, 2026 through July 31, 2028, supports basic and applied biomedical research aimed at identifying and developing medical solutions...
- The University of Southern California (USC) Department of Contracts and Grants Division was awarded a $331,630 Project Grant by the Defense Health Agency under the "Military Medical Research and Development" (CFDA 12.420) program. The grant supports research into mRNA delivery for polycystic kidney disease, with a period of performance from November 15, 2023 to November 14, 2025. As a leading private research university, USC leverages its expertise in engineering, health sciences,...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Regents of the University of California, San Francisco (UCSF) a $1,999,190 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective September 30, 2026, through September 29, 2030. This award supports UCSF's participation as a clinical research site within the Prostate Cancer Clinical Trials Consortium, a multi-institutional initiative focused on advancing prostate cancer research...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $1.4M under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco, effective July 1, 2026, through July 31, 2029. This project grant funds basic and applied biomedical research investigating the metabolic mechanisms of resistance to mutant isocitrate dehydrogenase (IDH) inhibition in gliomas. The research will be conducted at UCSF's San Francisco...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $235,476 project grant to the University of California, Los Angeles (UCLA) Office of Research Administration on November 1, 2025, to develop new cell-mediated immunotherapeutic strategies for neuroendocrine prostate cancer. The two-year award, which concludes October 31, 2027, is funded under the Military Medical Research and Development program (CFDA 12.420) and will be conducted at UCLA's Los Angeles, California facility....
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $559,976 to the University of California Irvine under the Military Medical Research and Development program (CFDA 12.420) on September 1, 2026, with a completion date of August 31, 2028. This two-year Project Grant funds research targeting mechanosensing PIEZO1 channels in CD8 T cells to enhance melanoma tumor immunity. The award supports investigator-initiated biomedical research aligned with DHA's mission to advance...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded University of California, Los Angeles a $799,999 Project Grant on May 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to support the project "From H&E to HRD: Linking Morphometry, Clinical, and Molecular Data for Drug Response Prediction." The award, with an ultimate completion date of April 30, 2030, funds biomedical research aimed at integrating histopathological imaging...
- This $1,992,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of a synthetic immune receptor for the treatment of prostate cancer. The award to the University of Southern California (USC) began on September 15, 2025 and is scheduled for completion on September 14, 2028. The project aims to advance biomedical research and innovative medical solutions that address critical health challenges...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded University of California, San Diego a $1.65 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2026, through June 30, 2029. The award supports research investigating nonneuronal acetylcholine receptor action in triple-negative breast cancer, a project focused on advancing understanding of molecular mechanisms relevant to breast cancer diagnostics and treatment...